Who Paid My Doc
M15-737 - Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson Disease
Research payments
$137,954
Through program year 2025, $137,954 in research payments was reported against M15-737 - Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson Disease, across 36 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $137,954 | 36 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Stephen Lee Lebanon, NH Named on 9 payments
- Jason Aldred Spokane, WA Named on 6 payments
- Sara Dhanani Sun City, AZ Named on 5 payments
- Mwiza Ushe Saint Louis, MO Named on 3 payments
- Eleni Vaou San Antonio, TX Named on 3 payments
- Jill Baird Vancouver, WA Named on 3 payments
- Drew Kern Aurora, CO Named on 2 payments
- Rajesh Pahwa Kansas City, KS Named on 2 payments
- Arjun Tarakad Houston, TX Named on 2 payments
- Elizabeth Peckham Round Rock, TX Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.